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Abstract 
In many clinical scenarios there exists more than one clinically appropriate intervention strategy. 
When these involve subjective trade-offs between potential benefits and harms, patients’ preferences 
should inform decision-making. Shared decision-making is a collaborative process, where clinician 
and patient reconcile the best available evidence with respect for patients’ individualized care 
preferences. In practice, clinicians may be poorly equipped to participate in this process. Shared 
decision-making is applicable to many conditions including stable coronary artery disease, end-of-life 
care, and numerous small decisions in chronic disease management. There is evidence of more 
clinically appropriate care patterns, improved patient understanding and sense of empowerment. 
Many trials reported a 20% reduction in major surgery in favour of conservative treatment, although 
demand tends to increase for some interventions. The generalizability of international evidence to 
Ireland is unclear. Considering the potential benefits, there is a case for implementing and evaluating 
shared decision-making pilot projects in Ireland. 
Introduction 
The traditional hallmark of high quality clinical care was accurate medical diagnosis, and formulation 
and execution of a treatment plan based on that diagnosis. But the frequent ambiguity of medical 
evidence and the changing expectations of patients demand other attributes. For some conditions 
(for example, a fractured femur) there is only one accepted treatment, and patient preferences have 
little relevance. But for many conditions there exists more than one acceptable path, and each choice 
entails distinct benefits, side effects and subjective trade-offs. In these preference-sensitive contexts, 
which may account for a quarter of all health care spending1, patients’ preferences and values can 
guide the intervention strategy. Shared decision making (SDM) is a process that allows patients and 
providers to make health care decisions collaboratively, taking into account the best available 
scientific evidence, as well as patient’s values and preferences. This can enhance clinical 
appropriateness, and improve communication, patients’ knowledge, and involvement in decision-
making. A study of 1,000 out-patient visits where more than 3,500 decisions were made found that 
fewer than 10% of decisions fulfilled minimum standards for informed decision making2, and the 
importance of improved decision-making is underscored by large variation in treatment patterns 
within health systems, unrelated to the availability of resources1. 
 
 
Methods 
We conducted a literature search on the topic of shared decision making in the PubMed database, 
using the following search term: ((((("shared decision making"[Title/Abstract]) OR "informed decision 
making"[Title/Abstract]) OR "informed medical decision making"[Title/Abstract])) AND 
(((quality[Title/Abstract]) OR evidence[Title/Abstract]) OR effectiveness[Title/Abstract])). The search 
was restricted to papers published from 2008 to 15th December 2013. A total of 843 papers were 
found. We included recent systematic and non-systematic literature reviews that summarize evidence 
and implementation challenges relating to SDM. We identified additional papers and books by 
searching the bibliographies of references, and the website of the Informed Medical Decisions 
Foundation. 
 
 
Results 
Examples of shared decision-making 
SDM is relevant for numerous clinical conditions associated with preference-sensitive care, such as 
bothersome lower urinary tract symptoms in men with benign prostatic hyperplasia. If a patient 
judges the surgical risks of incontinence and sexual dysfunction to outweigh the potential gains, there 
may be no need for surgery, despite capacity for clinical benefit. In a Canadian orthopaedic study, 
expert physicians identified patients in potential need of joint replacement based on symptoms and 
radiographic findings. Only 8-15% of these patients were “definitely willing” to undergo the 
intervention when informed of its evidence base3, illustrating the need to balance patients’ 
preferences with evidence. Table 1 presents a selection of relevant clinical scenarios and associated 
treatment options. 
 
 
SDM is also applicable to many types of care not traditionally considered preference-sensitive, 
including end-of-life care and the array of small decisions in chronic disease management. An elderly 
patient with Parkinson’s Disease may prioritise certain forms of functionality such as the ability to 
communicate with relatives over the internet, whereas a physician may define treatment success in 
narrow terms of biomedical metrics such as presence of tremor. Aggressively optimising particular 
clinical targets may compromise overall quality of life7. In such situations it is sensible to elicit and 
account for the patient’s specific values and goals. 
 
Tools for shared decision-making 
SDM should convey up-to-date scientific evidence to patients in a comprehensible manner. One 
strategy is to train clinicians in communication skills and facilitation of SDM. Systematic reviews show 
this may improve communication, patients’ understanding, and satisfaction, but there is no firm 
evidence of altered clinical outcomes and utilisation patterns8. Another approach is adoption of 
decision aid tools, which inform patients on the risks and benefits of diagnostic and treatment 
strategies. For example, the Prostate Interactive Education System presents information on prostate 
cancer treatment in an interactive format. Patients can access the decision aid freely online and 
examine texts and videos on the rationale for treatment options such as external beam radiation, 
robotic surgery, and watchful waiting (active surveillance)9. It holistically deals with family and 
relationship issues arising from prostate cancer. For example, a section for women offers written 
advice and videos of women discussing methods for dealing with a spouse’s illness, medical 
decision-making, social interactions with family and friends, and side effects of treatment. On the 
topic of radical prostatectomy, there are video simulations of physician counselling for topics such as 
pain, relative effectiveness, and interaction with medicines. 
 
What does the evidence say? 
A recent Cochrane review summarises much of the evidence for decision aids addressing treatment 
or screening decisions. It showed improved patient-clinician communication, superior patient 
enthusiasm, knowledge, understanding of trade-offs, and involvement in decision-making. The 
effects on consultation length were inconsistent. There appeared to be no adverse effects on patient 
satisfaction or clinical outcomes10. Adoption of decision aids was associated with a 20% reduction in 
utilisation of major surgery in favour of conservative treatment, reduced use of PSA screening, and 
reduced use of post-menopausal hormones. A study found that women in the United Kingdom 
suffering from abnormal uterine bleeding, when informed properly of the risks and benefits chose 
surgery significantly less often (relative reduction of 20%). Patients with back pain and herniated 
disks were 30% less likely to choose surgery when fully informed10. Some demand may be 
postponed rather than obviated. The economic consequences are unclear. Reduced utilization may 
not translate into reduced net costs, as this is influenced by implementation costs and the sensitivity 
of cost structures to reduced demand. The generalizability of utilization reductions is unclear. Much 
evidence is from the predominantly market-oriented US system, and some comes from settings such 
as Canada and the United Kingdom6,10. The effects may vary across settings depending on baseline 
provision rates. The goal is to avoid both overuse and underuse rather than to uniformly temper 
demand. SDM tends to increase demand for some interventions such as spinal stenosis surgery 
 
Caveats and limitations 
Do patients truly want the added responsibility of SDM? Some patients may prefer to delegate the 
burden of decision-making to a clinician, and SDM may be incongruent with patients’ psychosocial 
needs, especially in the face of far-reaching uncertainty, fear and distress. If patients (or their 
families) choose a treatment that culminates in poor outcomes, the ensuing guilt may amplify anguish 
and regret. Nonetheless evidence suggests SDM has high levels of acceptability with patients and 
can improve the care experience. In one provider organisation, 76% of patients over 65 years would 
“strongly recommend” use of a decision aid prior to deciding on a surgical procedure11. In a study of 
20 women with suspected recurrent ovarian cancer, 95% would recommend the use of a decision 
aid, despite its association with high anxiety levels12. 
 
SDM may impose a cognitive burden unsuitable for some patients. People are prone to inconsistent 
and irrational decision-making, and framing the same evidence in different ways can alter 
perceptions of effectiveness, for example patients and physicians may perceive a “10% mortality 
rate” differently from a “90% survival rate”13. Studies suggest that physicians and patients frequently 
misinterpret statistical evidence6. Mammography screening for breast cancer has a miss rate of 
around 10%, and its false positive rate is only slightly lower, but in a German study 46% of women 
(and 42% of men) reported it as “absolutely certain”. SDM must be carefully structured to overcome 
such misunderstanding. 
 
 
Discussion 
Implementation of SDM touches on cultural issues, and it can be difficult to alter established work 
practices. In a Veterans Administration hospital, a decision aid for benign prostatic hyperplasia 
lowered the demand for surgical procedures and maintained patient satisfaction, but its use was 
terminated after the volume of surgeries became insufficient for urology residents to attain board 
certification14. In a study of SDM in end-of-life care, treatment intensity persistently exceeded 
patients’ recorded preferences15. It is unclear if clinicians disregarded patients’ preferences, or 
whether unmeasured changes in patients’ preferences occurred as death approached. The prevailing 
medical culture urges clinicians to do their utmost to heal, and this may inadvertently deter tempering 
of treatment intensity in accordance with patient preferences. SDM may prove a key tool for Irish 
clinicians to reconcile evidence-based medicine with individualized care. Successful implementation 
could substantially influence patterns of clinical care, and this demands multi-stakeholder 
commitment to improvement. 
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